EPISODE 54: What FDA Approval Actually Means and the Future of Peptides with Dr. Jean Cunningham

EPISODE 54: What FDA Approval Actually Means and the Future of Peptides with Dr. Jean Cunningham

July 17, 2026 · 1h 18m · Season 1 · Episode 54

About this episode

Dr. Jean Cunningham discusses the implications of FDA approval and the future of peptide therapies in women's health.

Welcome back to Peptides for Women podcast! In this episode, I’m joined by Dr. Jean Cunningham , Senior Director of Medical Affairs at Empower Pharmacy. With over 15 years of experience in pharmacy, medical affairs, scientific communications, and evidence-based healthcare, Dr. Cunningham brings a unique perspective on peptides, GLP-1s, women’s health, and the evolving regulatory landscape surrounding compounding pharmacies. Together, we dive into the science behind peptide therapies, the role of GLP-1 medications beyond weight loss, the history of hormone replacement therapy, and what the FDA’s upcoming peptide discussions could mean for patients, providers, and the future of personalized medicine. In this episode, we cover: Dr. Cunningham’s journey from pharmacy school to medical affairs leadership Why evidence-based medicine matters, and how to evaluate research critically The lasting impact of the Women's Health Initiative on hormone replacement therapy Why many women were underserved by traditional healthcare approaches How GLP-1 medications have evolved over the past two decades The connection between obesity, inflammation, and chronic disease The difference between visceral…

More episodes of Peptides for Women

Explore listener stats, chart rankings, contacts and more on the Peptides for Women podcast page.